Navigation Links
Systematic Review of Patient-Reported Outcomes (PROs) Can Reduce Cost of Cancer Care
Date:4/28/2008

Supportive Oncology Services, Inc. leads PRO collection in community

oncology

MEMPHIS, Tenn., April 28 /PRNewswire/ -- Supportive Oncology Services (SOS), Inc. a research-based health-outcomes company specializing in oncology, issued the following statement today regarding the impact of Patient-Reported Outcomes (PROs) in the cancer community.

"Appropriate use of PRO information in the community oncology setting and timely intervention can significantly reduce the cost of patient care," according to Steve Coplon, CEO. "Avoidance of hospitalization dramatically reduces costs to treat cancer and improve health outcomes. For example, in our area an acute case requiring hospitalization for febrile neutropenia costs approximately $28,000 per event; hospitalization for anemia costs $23,000 per event; and hospitalization for severe nausea/vomiting costs $13,000 per event."

Dr. Kurt Tauer, Senior Partner with The West Clinic-Memphis states, "Conservatively, we keep over 75 patients per week out of the hospital and emergency room. Many of these avoided admissions are a direct result of patient self-reported assessments we collect via the PACE System(TM) e/Tablet. This crucial information enables our physicians to make appropriate interventions. We hear similar results from other community-based cancer clinics across the country."

The value of PROs in caring for the patient and potentially predicting and avoiding negative outcomes has been recently recognized by the Institute of Medicine (Cancer Care for the Whole Patient, 2008) and research published in the Journal of Clinical Oncology (J Clin Oncol 26:1355-1363). Additionally, Duke University's Cancer Program recognized the importance of PROs and implemented The PACE System(TM) in research projects across its Oncology Supportive Care department.

In April 2008, SOS announced it had accrued over one million cancer patient self-reported assessments using the PACE(TM) electronic e/Tablet system. Aggregated data from these self-assessments provides a rich resource for oncology research.

"All formal studies of the PACE(TM) System have proven that a more thorough and frequent assessment of the patient occurs when PROs are gathered by e/Tablets," affirms Edward J. Stepanski, PhD, Chief Operating Officer for SOS. "There is increasing recognition that PROs are the most accurate measure of symptoms and side effects. Thus, when clinicians routinely gather more, higher quality data and take action, good things happen for the patient."

For additional information contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878 or visit http://www.SupportiveOncologyServices.com.

About Supportive Oncology Services, Inc. (SOS)

Supportive Oncology Services, Inc. (SOS), an information and outcomes company, works closely with community oncology practices and oncology academic centers which provide treatment for over a half million cancer patients across the US. SOS also collaborates with bio-technology and pharmaceutical companies, the financial industry, payers, and other cancer-related industry leaders on diverse clinical, financial, and operational initiatives. By continuously offering improvements, measuring results and providing value, SOS helps define and improve the quality of cancer care provided.

Liz Conway

901-435-5570

Cell: 901-486-4872

lconway@sosacorn.com

Deborah D. Coble

901-683-0055 x1312

Cell: 901-831-1010

dcoble@sosacorn.com


'/>"/>
SOURCE Supportive Oncology Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Diabetes Educator publishes systematic reviews for diabetes management
2. Methadone and systematic follow-up: the best solution for managing chronic pain
3. SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions
4. Review Urges Aggressive MRSA Screening for Health Workers
5. ACC Calls on FDA to Update Review of Bisphenol A
6. Press Preview to Unveil Miracle Manny
7. PreMD Provides Update on FDA Review
8. Neuroscience Peer Review Consortium announces increased journal participation
9. ExoSeal vascular plug gets good reviews in ECLIPSE study
10. Symmetry Medical Delays 10-K Filing to Complete Review
11. Review of group-based cancer trials reveals flaws in studies design and analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: